Sonnet BioTherapeutics Holdings - Stock Price History | SONN

Historical daily share price chart and data for Sonnet BioTherapeutics Holdings since 2021 adjusted for splits. The latest closing stock price for Sonnet BioTherapeutics Holdings as of September 27, 2021 is 0.63.
  • The all-time high Sonnet BioTherapeutics Holdings stock closing price was 84331.25 on October 31, 2006.
  • The Sonnet BioTherapeutics Holdings 52-week high stock price is 3.42, which is 442.9% above the current share price.
  • The Sonnet BioTherapeutics Holdings 52-week low stock price is 0.55, which is 12.7% below the current share price.
  • The average Sonnet BioTherapeutics Holdings stock price for the last 52 weeks is 1.97.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sonnet BioTherapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 97.8143 391.2970 688.1430 2.2300 2.2300 -99.44%
2019 764.5841 910.7775 1450.4976 344.1390 398.0435 -54.26%
2018 1951.9636 2509.6981 2779.6256 870.2985 870.2985 -50.95%
2017 2022.7887 2833.5301 3305.7851 1281.8350 1774.2621 -37.38%
2016 4042.3263 6813.9653 6813.9653 2604.8237 2833.5301 -57.97%
2015 13330.6347 12211.1655 26513.7460 5903.1877 6742.4524 -42.05%
2014 18067.3830 34069.8263 34339.6863 10119.7504 11635.6890 -67.88%
2013 23644.0900 24557.2609 37847.8664 10996.1208 36228.7064 47.53%
2012 33565.9356 49924.1019 53972.0020 22870.6359 24557.2609 -50.81%
2011 40443.1273 28672.6261 67465.0025 28200.3711 49924.1019 74.12%
2010 26636.6287 26986.0010 28672.6261 20239.5008 28672.6261 6.25%
2009 25805.0957 38792.3765 38792.3765 6813.9653 26986.0010 -30.43%
2008 43741.5877 33732.5013 53972.0020 33732.5013 38792.3765 10.58%
2007 59250.9369 74211.5028 74211.5028 34407.1513 35081.8013 -52.73%
2006 63208.2822 84331.2532 84331.2532 33732.5013 74211.5028 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.016B $0.041B
Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29